Skip to content
Search

Latest Stories

Shah Rukh Khan’s first look from Pathan to be unveiled on 1st January 2021?

Murtuza Iqbal

A few weeks ago, Shah Rukh Khan kickstarted the shooting of Siddharth Anand’s Pathan. The movie is produced by Yash Raj Films, but the makers have not yet announced it officially.


Well, we haven’t even got a glimpse of the actor shooting for the film. Now, according to a report in Bollywood Hungama, Aditya Chopra, the head-honcho of YRF, has planned a grand unveiling of Shah Rukh Khan’s first look from the film on 1st January 2021.

A source told the entertainment portal, “Pathan is going to be Shah Rukh Khan’s biggest film till date, and Aditya Chopra is making sure of that. In fact, the grapevine is buzzing with reports that Adi and YRF are planning a grand unveiling of SRK’s look from Pathan on January 1, 2021.”

“As of now this unveiling is just unconfirmed reports, but an official announcement about the film will be made with this look unveiling. If you see, YRF has been tight-lipped about Pathan, but they will make sure to hype it up, and what better way than with an announcement to herald the New Year?” added the source.

Pathan will mark SRK’s comeback on the big screen after a gap of three years. His last film was the 2018 release Zero. Interestingly, the first look of Zero was also unveiled on 1st January (2018).

Directed by Siddharth Anand, Pathan also stars John Abraham and Deepika Padukone. Reportedly, the film will hit the big screens on Diwali next year.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less